The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NETTER-1 phase III: Efficacy and safety results in patients with midgut neuroendocrine tumors treated with 177Lu-DOTATATE.
 
Jonathan R. Strosberg
Honoraria - Novartis
Consulting or Advisory Role - Lexicon; Novartis
Speakers' Bureau - Genentech; Ipsen
Research Funding - Novartis; Pharmacyclics
 
Edward M. Wolin
Consulting or Advisory Role - Advanced Accelerator Applications; Novartis
 
Beth Chasen
No Relationships to Disclose
 
Matthew H. Kulke
Consulting or Advisory Role - Ipsen; Novartis
 
David L Bushnell
Research Funding - Advanced Accelerator Applications
 
Martyn E. Caplin
Honoraria - Ipsen; Lexicon; Novartis
Consulting or Advisory Role - Ipsen; Lexicon; Novartis
Speakers' Bureau - Ipsen; Lexicon; Novartis
Research Funding - Ipsen; Lexicon; Novartis
 
Richard P. Baum
Research Funding - Advanced Accelerator Applications
 
Timothy J. Hobday
Research Funding - Advanced Accelerator Applications
 
Andrew Eugene Hendifar
Travel, Accommodations, Expenses - Halozyme
 
Kjell E. Oberg
Honoraria - Ipsen; Novartis
Consulting or Advisory Role - Ipsen; Novartis
Speakers' Bureau - Ipsen; Novartis
Travel, Accommodations, Expenses - Ipsen; Novartis
 
Maribel Lopera Sierra
Employment - Advanced Accelerator Applications (I)
Leadership - Advanced Accelerator Applications (I)
Stock and Other Ownership Interests - Advanced Accelerator Applications
 
Dik J. Kwekkeboom
Stock and Other Ownership Interests - Advanced Accelerator Applications
 
Philippe B. Ruszniewski
Honoraria - Advanced Accelerator Applications; Ipsen; Novartis
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; Novartis
Research Funding - Ipsen; Novartis
Travel, Accommodations, Expenses - Ipsen
 
Eric Krenning
Stock and Other Ownership Interests - Advanced Accelerator Applications
Patents, Royalties, Other Intellectual Property - Advanced Accelerator Applications; Mallinckrodt
Other Relationship - Advanced Accelerator Applications
 
Pamela L. Kunz
Stock and Other Ownership Interests - Guardant Health
Consulting or Advisory Role - Ipsen; Lexicon; Novartis
Research Funding - Advanced Accelerator Applications; Genentech/Roche; Lexicon; Merck; Merrimack; Novartis; Oxigene